HDL

Quote






Atherotech, HDL, etc and other labs selling panels and have some form of this model will eventually be out of business based on market conditions or the carriers and or government will expose them. I now realize we are illegal borderline, not too mention the havoc we cause customers and the wasteful $$$$ being cheated from the healthcare system.
 






We are not a lab that are accounts can rely upon. We are a gimmick, peddling medically unnecessary testing. Our accounts quickly realize all the problems we bring to their door step and stop using us once they see the expense to patient and insurance. I can already feel the resistance from the physicians office and even the patients don't like us!!!!!!
 












Sounds like you all agree that you are peddling large panels that are not medically necessary? And that someone else is "making you do it"? And why did you come to work for a cardio-metabolic lab if you do not believe that disease-state panels are relevant?
I hear and see the difference my (evidently smaller and more reasonable) panels have made in patient care. No one can force me to do anything wrong. As long as CVD is still the biggest killer of males and females, nationally, above all other causes of mortality added together; I have a defensible case for what I sell.
Unfortunately, none of this matters --And I reiterate--None of this matters if we are unable to execute a reasonable, legal and consistent billing strategy across the board so that patients have access. Goodbye OON's. That part of the business is toast. The remaining in-network patients, should you be fortunate and have a large number of them in your geography, can be decent business going forward. Will your HCP's see enough value in what you sell to remain loyal and cleave off those in-network patients for you? Will you renegotiate their panels to make them smaller, using an "increase in shared cost" argument? Overnight, selling this business got way more complicated that it already was. I have no problem telling a bad RD to bite me. However, there is unresolved conflict in my head when it comes to coaching HCP's in their practice of medicine, where they must knowingly insert a sizeable gap in clinical benefit due to the patient being OON. To me, this is where the game gets dicey. For sure, the patients who are OON will not get the same care as one who is in-network.
 






Anonymous said:
Sounds like you all agree that you are peddling large panels that are not medically necessary? And that someone else is "making you do it"? And why did you come to work for a cardio-metabolic lab if you do not believe that disease-state panels are relevant?
I hear and see the difference my (evidently smaller and more reasonable) panels have made in patient care. No one can force me to do anything wrong. As long as CVD is still the biggest killer of males and females, nationally, above all other causes of mortality added together; I have a defensible case for what I sell.
Unfortunately, none of this matters --And I reiterate--None of this matters if we are unable to execute a reasonable, legal and consistent billing strategy across the board so that patients have access. Goodbye OON's. That part of the business is toast. The remaining in-network patients, should you be fortunate and have a large number of them in your geography, can be decent business going forward. Will your HCP's see enough value in what you sell to remain loyal and cleave off those in-network patients for you? Will you renegotiate their panels to make them smaller, using an "increase in shared cost" argument? Overnight, selling this business got way more complicated that it already was. I have no problem telling a bad RD to bite me. However, there is unresolved conflict in my head when it comes to coaching HCP's in their practice of medicine, where they must knowingly insert a sizeable gap in clinical benefit due to the patient being OON. To me, this is where the game gets dicey. For sure, the patients who are OON will not get the same care as one who is in-network.
Click to expand...

Geez this is a real idiot.
 












Anonymous said:
Sounds like you all agree that you are peddling large panels that are not medically necessary? And that someone else is "making you do it"? And why did you come to work for a cardio-metabolic lab if you do not believe that disease-state panels are relevant?
I hear and see the difference my (evidently smaller and more reasonable) panels have made in patient care. No one can force me to do anything wrong. As long as CVD is still the biggest killer of males and females, nationally, above all other causes of mortality added together; I have a defensible case for what I sell.
Unfortunately, none of this matters --And I reiterate--None of this matters if we are unable to execute a reasonable, legal and consistent billing strategy across the board so that patients have access. Goodbye OON's. That part of the business is toast. The remaining in-network patients, should you be fortunate and have a large number of them in your geography, can be decent business going forward. Will your HCP's see enough value in what you sell to remain loyal and cleave off those in-network patients for you? Will you renegotiate their panels to make them smaller, using an "increase in shared cost" argument? Overnight, selling this business got way more complicated that it already was. I have no problem telling a bad RD to bite me. However, there is unresolved conflict in my head when it comes to coaching HCP's in their practice of medicine, where they must knowingly insert a sizeable gap in clinical benefit due to the patient being OON. To me, this is where the game gets dicey. For sure, the patients who are OON will not get the same care as one who is in-network.
Click to expand...


Amen. I work for a competitor & I completely agree with you. You are spot on & the rest of these reps obviously don't quite understand what they are selling & why! It's about saving lives & bringing value to your physicians!
 












Anonymous said:
Amen. I work for a competitor & I completely agree with you. You are spot on & the rest of these reps obviously don't quite understand what they are selling & why! It's about saving lives & bringing value to your physicians!
Click to expand...


the problem is we have become very disruptive in accounts and bring tremendous baggage with lack of interface capabilities, pick ups limited, turn times, managed care letters, patient complaints and the list is long and painful if you care about a client. we are a lab that has one test to promote the rest can be performed at any of the big contracted labs and even with esoteric tests are reported quicker because of interfaces. we got off track and we think atherotech can compete which is not the case. we are a 3rd rate small lab with zero strategy now.
 












Top Bottom
Back
Quote